首页>
外国专利>
Use of the TRAP protein itself as an active ingredient for the manufacture of a medicament for the treatment of Staphylococcus aureus infections
Use of the TRAP protein itself as an active ingredient for the manufacture of a medicament for the treatment of Staphylococcus aureus infections
展开▼
机译:TRAP蛋白本身作为活性成分在制备用于治疗金黄色葡萄球菌感染的药物中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention discloses the use of TRAP per se as an active ingredient for the manufacture of a medicament for the treatment of Staphylococcus aureus infection. An exogenous TRAP (native TRAP or recombinant TRAP) per se can effectively inhibit the production of Staphylococcus aureus exotoxins, thereby reducing the pathogenicity of Staphylococcus aureus. In addition, a medicament comprising TRAP also stimulates the production of corresponding antibodies in human body at the time when it is used to treat Staphylococcus aureus infections, and these antibodies can further inhibit the production of Staphylococcus aureus exotoxins. Such double actions increase the effects of medicament and provide a novel medicament action mode. Moreover, since TRAP functions merely to the toxicity of bacteria but does not affect the growth of bacteria, it cannot make bacteria readily develop drug resistance, and also effective to drug resistant Staphylococcus aureus. Moreover, no homologous sequence of the TRAP proteins of the present invention is found in human genome, so that the medicaments of TRAP cannot cause human immunologic diseases.
展开▼